Elanco EVP disposes 4,322 shares for tax withholding

Elanco Animal Health Inc executive Grace McArdle, EVP, Manufacturing and Quality, reported a tax-related share disposition.

Accepted by SEC EDGAR 03/05/2026 - 04:10 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Elanco Animal Health Inc executive Grace McArdle, EVP, Manufacturing and Quality, reported a tax-related share disposition. On March 3, 2026, she disposed of 4,322 shares of Elanco common stock at $24.88 per share in a transaction classified as a tax-withholding disposition, meaning shares were delivered to cover tax obligations rather than sold in an open-market trade. Following this transaction, she directly held 103,705 shares of Elanco common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 4,322 shares

Exercise Price or Tax Liability 1 txn

Insider McArdle Grace

Role EVP, MANUFACTURING AND QUALITY

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	4,322	$24.88	$108K

Holdings After Transaction: Common Stock — 103,705 shares (Direct)

Holdings Before and After: Common Stock, 108,027 to 103,705 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elanco (ELAN) report for Grace McArdle?

Elanco reported that executive Grace McArdle disposed of 4,322 shares of common stock on March 3, 2026. The transaction was a tax-withholding disposition, meaning shares were delivered to satisfy tax obligations rather than executed as an open-market sale.

How many Elanco (ELAN) shares did Grace McArdle dispose of and at what price?

Grace McArdle disposed of 4,322 Elanco common shares at $24.88 per share on March 3, 2026. The transaction was coded as a tax-withholding disposition, reflecting payment of tax liabilities using company stock instead of cash.

How many Elanco (ELAN) shares does Grace McArdle hold after this Form 4 transaction?

After the March 3, 2026 transaction, Grace McArdle directly held 103,705 shares of Elanco common stock. This figure reflects her ownership following the 4,322-share tax-withholding disposition reported in the Form 4 filing.

What does a tax-withholding disposition mean in the Elanco (ELAN) Form 4?

A tax-withholding disposition means shares are delivered to cover tax liabilities, not sold on the open market. In this case, 4,322 Elanco shares at $24.88 each were used to satisfy tax obligations tied to McArdle’s equity compensation.

What role does Grace McArdle hold at Elanco (ELAN) in this Form 4 filing?

In this Form 4, Grace McArdle is identified as an officer of Elanco, serving as Executive Vice President, Manufacturing and Quality. The reported transaction reflects her personal equity activity related to this executive position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McArdle Grace

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

46221

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, MANUFACTURING AND QUALITY

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		F		4,322	D	$24.88	103,705	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Amy C. Seidel, as Attorney-in-Fact for Grace McArdle	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR